Drug Development for Nonalcoholic Fatty Liver Disease: Landscape and Challenges. (2019)
Attributed to:
Nottingham Molecular Pathology Node (NMPN) for Integrated Multi-platform Biomarker Research and Knowledge Transfer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jceh.2019.03.002
PubMed Identifier: 31516268
Publication URI: http://europepmc.org/abstract/MED/31516268
Type: Journal Article/Review
Volume: 9
Parent Publication: Journal of clinical and experimental hepatology
Issue: 4
ISSN: 0973-6883